BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30239826)

  • 1. The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer.
    Lee J; Han HJ; Min BS; Hong SP; Shin SJ; Yoon HI; Park SJ; Koom WS
    Jpn J Clin Oncol; 2018 Nov; 48(11):988-994. PubMed ID: 30239826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma.
    Wachter S; Gerstner N; Goldner G; Pötzi R; Wambersie A; Pötter R
    Radiother Oncol; 2000 Jan; 54(1):11-9. PubMed ID: 10719695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients.
    Goldner G; Tomicek B; Becker G; Geinitz H; Wachter S; Zimmermann F; Wachter-Gerstner N; Reibenwein J; Glocker S; Bamberg M; Feldmann H; Pötzi R; Molls M; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):78-83. PubMed ID: 17189064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic findings of rectal mucosal damage after pelvic radiotherapy for cervical carcinoma: correlation of rectal mucosal damage with radiation dose and clinical symptoms.
    Kim TG; Huh SJ; Park W
    Radiat Oncol J; 2013 Jun; 31(2):81-7. PubMed ID: 23865004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of relative and absolute rectal dose-volume parameters and clinical correlation with acute and late radiation proctitis in prostate cancer patients.
    Paleny R; Bremer M; Walacides D; Mainwaring S; Weber K; Henkenberens C
    Strahlenther Onkol; 2019 Feb; 195(2):103-112. PubMed ID: 30191285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer.
    Campostrini F; Remo A; Astati L; Zorzi M; Capodaglio G; Buffoli A; Moretti G; Della Monica B; Zanella C; Verlato G
    Strahlenther Onkol; 2020 Jul; 196(7):617-627. PubMed ID: 32166451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer.
    Sood S; Ju AW; Wang H; Lei S; Uhm S; Zhang G; Suy S; Carroll J; Lynch J; Dritschilo A; Collins SP
    Radiat Oncol; 2013 Aug; 8():197. PubMed ID: 23937800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proctitis following stereotactic body radiation therapy for prostate cancer.
    Joh DY; Chen LN; Porter G; Bhagat A; Sood S; Kim JS; Moures R; Yung T; Lei S; Collins BT; Ju AW; Suy S; Carroll J; Lynch JH; Dritschilo A; Collins SP
    Radiat Oncol; 2014 Dec; 9():277. PubMed ID: 25497602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE).
    Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Huang EY; Hsiung CY; Changchien CC
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):85-91. PubMed ID: 9422562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy.
    Goldner G; Pötter R; Kranz A; Bluhm A; Dörr W
    Strahlenther Onkol; 2011 Mar; 187(3):202-5. PubMed ID: 21347635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer.
    Ippolito E; Guido A; Macchia G; Deodato F; Giaccherini L; Farioli A; Arcelli A; Cuicchi D; Frazzoni L; Cilla S; Buwenge M; Mantini G; Alitto AR; Nuzzo M; Valentini V; Ingrosso M; Morganti AG; Fuccio L
    In Vivo; 2017; 31(5):961-966. PubMed ID: 28882966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric factors predicting severe radiation-induced bowel complications in patients with cervical cancer: combined effect of external parametrial dose and cumulative rectal dose.
    Huang EY; Wang CJ; Hsu HC; Hao Lin ; Chen HC; Sun LM
    Gynecol Oncol; 2004 Oct; 95(1):101-8. PubMed ID: 15385117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late rectal toxicity after low-dose-rate brachytherapy: incidence, predictors, and management of side effects.
    Kishan AU; Kupelian PA
    Brachytherapy; 2015; 14(2):148-59. PubMed ID: 25516492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study.
    Rijkmans EC; Marijnen CAM; van Triest B; Ketelaars M; Cats A; Inderson A; van den Ende RPJ; Laman MS; Kerkhof EM; Nout RA
    Radiother Oncol; 2019 Apr; 133():176-182. PubMed ID: 30935576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor and its correlation with clinical symptoms and endoscopic findings in patients with chronic radiation proctitis.
    Trzcinski R; Dziki A; Brys M; Moszynska-Zielinska M; Chalubinska-Fendler J; Mik M; Kujawski R; Dziki L
    Colorectal Dis; 2018 Apr; 20(4):321-330. PubMed ID: 28963746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence and clinical consequences of treatment-related bowel injury.
    Miller AR; Martenson JA; Nelson H; Schleck CD; Ilstrup DM; Gunderson LL; Donohue JH
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):817-25. PubMed ID: 10098437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcome and Risk Factors of Chronic Radiation Proctitis Following Pelvic Radiation Therapy.
    Im CM; Cho IJ; Yu HJ; Han B; Oh HH; Seo YJ; Kim KH; Myung DS; Cho SB; Lee WS; Nam TK; Joo YE
    Anticancer Res; 2022 Dec; 42(12):5951-5959. PubMed ID: 36456158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
    Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial.
    Cheng YK; Qin QY; Huang XY; Lan P; Wang L; Gao X; Ma TH
    Cancer Med; 2020 Feb; 9(3):912-919. PubMed ID: 31828956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.